Invited Talks
- Microwave Dielectric Analysis of Wet Granulations for Erodible HPMC Tablets, Proceedings of the 138th British Pharmaceutical Conference, Glasgow, United Kingdom,
September, 2001.
- Chronopharmaceutical Drug Delivery, University of Texas at Austin, Austin, TX, October, 2001.
- Particle Engineering Technologies: Theory and Practice, Annual Meeting of the American Association of Pharmaceutical Scientists, Baltimore, MD, November, 2004.
- Capsule Filling and Topical Formulations, Science Camp Presentation, Priscilla Pond Flawn Child and Family Laboratory, University of Texas at Austin, Austin, TX, June,
2005.
- Pre-Clinical Development Studies with Poorly Water-Soluble Drugs, Universidade Federal de Minas Gerais, Belo Horizonte, Brasil, June, 2005.
- Targeted High Lung Concentrations of Itraconazole using Nebulized Dispersions in a Murine Model, Joint Symposium on the Future Prospects of Pharmaceutical Sciences,
Hoshi University, Tokyo, Japan, October, 2005.
- Pre-Clinical Development Studies with Poorly Water-Soluble Drugs, University of Louisiana at Monroe, Monroe, LA, January, 2006.
- The Effective Delivery of Itraconazole for the Treatment of Acute Fungal Infections, University of Mississippi, Oxford, MS, January, 2006.
- Targeted High Lung Concentrations of Itraconazole using Nebulized Dispersions in a Murine Model, University of Texas at Austin, Austin, TX, February, 2006.
- Enhanced Therapeutic Outcomes using Targeted Itraconazole Delivery in a Murine Model, Long Island University, Brooklyn, NY, February, 2006.
- Targeted Treatment of Infectious Diseases to the Lung, Virginia Commonwealth University, February, 2007.
- Targeted Lung Delivery of Antifungals: Preclinical Studies using Itraconazole Nanoparticles, Respiratory Drug Delivery Meeting in Europe, Paris, France, April,
2007.
- Preclinical Studies with Poorly Water Soluble Drugs, University of Strathclyde, Glasgow, UK, July, 2007.
- Antifungal Prophylaxis to Treat Pulmonary Aspergillosis, GEA-NUS 10th Anniversary Celebration & Pharmaceutical Technology Seminar, Singapore, December,
2007.
- Novel In Vitro Dissolution Testing Methods for Inhalation Formulations, Dissolution Testing, Bioequivalence & Bioavailability Strategies Meeting, London,
United Kingdom, June 2008.
- Dissolution Testing of Inhalation Products, Copley Scientific Ltd, London, United Kingdom, June 2008.
- Modification of the USP Type II Dissolution Testing Apparatus for Powder Formulations, Novartis, Basel, Switzerland, July 2008.
- The Use of Renewable Ingredients for Pharmaceutical Formulations, Tate & Lyle, Decatur, September 2008.
- Improved Therapy by Direct Lung Targeting for the Treatment of Pulmonary Aspergillosis, Purdue University, September, 2008.
|
Justin Hughey, graduate student of Dr. James McGinity, has been awarded a graduate student scholarship by the International Pharmaceutical Excipients Council of the Americas Foundation.
